Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
buyouts
Pharma
FTC to review Novo Holdings' Catalent buyout for another month
Despite a new 30-day extension on the FTC's review of Novo Holdings' Catalent buyout, the CDMO giant still expects the deal to close by year-end 2024.
Fraiser Kansteiner
May 3, 2024 2:00pm
After 17-year courtship, Sun and Taro agree on $348M buyout
Jan 18, 2024 11:23am
OptimizeRx spends $95M to snap up Medicx Health
Oct 17, 2023 3:20pm
Dire straits detailed for Epizyme before buyout by Ipsen
Jul 13, 2022 8:46am